November 17, 2026
Uncategorized

Patent wins vs tariff risks: Analysts picks top pharma stocks to bet on (Soban News)

Pharma stocks have, so far, outperformed the markets in 2026. However, as risk around Trump tariffs resurface, analysts suggest shifting to domestic-focused companies. Here’s the investment strategy.​Pharma stocks have, so far, outperformed the markets in 2026. However, as risk around Trump tariffs resurface, analysts suggest shifting to domestic-focused companies. Here’s the investment strategy. ​Latest News [ SOBAN NEWS: International and National ]

Related posts

PNGS Reva Diamond IPO disappoints on debut; shares list at 4% discount (Soban News)

News-Soban-Admin

Indian asset managers dump government bonds at record pace on oil shock (Soban News)

News-Soban-Admin

Land-for-job scam: Court defers framing of charges against Lalu to Dec 4 (Soban News)

News-Soban-Admin

Leave a Comment